ExpreS2ion Biotech Holding AB's total assets for Q4 2025 were kr65.11M, an increase of 5.41% from the previous quarter. SE:EXPRS2 total liabilities were kr29.42M for the fiscal quarter, a 3.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.